01 1ASCLERA
02 1CYTALUX
03 1DACOGEN
04 10DECITABINE
05 1VARITHENA
01 121201
02 121790
03 1202969
04 1203131
05 1203475
06 1205098
07 1205539
08 1206033
09 1208601
10 1209056
11 1210756
12 1210984
13 1212265
14 1214907
01 12No
02 2Yes
Drug : ASCLERA
Dosage Form : SOLUTION; INTRAVENOUS
Application Number : 21201
Country : US
Patented : No
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Drug : DECITABINE
Dosage Form : INJECTABLE; INTRAVENOUS
Application Number : 203131
Country : US
Patented : No
Drug : DECITABINE
Dosage Form : INJECTABLE; INTRAVENOUS
Application Number : 203475
Country : US
Patented : No
Drug : DECITABINE
Dosage Form : INJECTABLE; INTRAVENOUS
Application Number : 206033
Country : US
Patented : No
Drug : DECITABINE
Dosage Form : INJECTABLE; INTRAVENOUS
Application Number : 208601
Country : US
Patented : No
Drug : DECITABINE
Dosage Form : INJECTABLE; INTRAVENOUS
Application Number : 205539
Country : US
Patented : No
Drug : DECITABINE
Dosage Form : INJECTABLE; INTRAVENOUS
Application Number : 210756
Country : US
Patented : No
Drug : DECITABINE
Dosage Form : INJECTABLE; INTRAVENOUS
Application Number : 212265
Country : US
Patented : No
Drug : DACOGEN
Dosage Form : INJECTABLE; INTRAVENOUS
Application Number : 21790
Country : US
Patented : No
Drug : VARITHENA
Dosage Form : SOLUTION; INTRAVENOUS
Application Number : 205098
Country : US
Patented : Yes
